U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood Grouping Regent, Anti-E (Human Monoclonal)
  1. Vaccines, Blood & Biologics

Blood Grouping Regent, Anti-E (Human Monoclonal)

STN#: 125443
Proper Name: Blood Grouping Reagent, Anti-E (Human Monoclonal) (FFMU)
Tradename: (None)
Manufacturer: DIAGAST, License #1887
Indication:

  • This and other Blood Grouping Reagents (For Further Manufacturing Use) listed in the approval letter are indicated for use in the manufacture of Blood Grouping Reagents, Anti-B, Anti-D and Anti-E by Diagnostic Grifols S.A. (Spain) U.S. License No. 1887, to produce in vitro product Blood Grouping Reagents (BGR) under a shared manufacturing arrangement.
Back to Top